The IBS-D diagnosis your colonoscopy missed
Roughly 30% of IBS-D patients actually have bile acid diarrhea — a treatable transport disorder that doesn't show up on colonoscopy, calprotectin, or CRP. The four-tier bile acid testing pathway, where each marker is purchaseable DTC, and how the rare 7αC4 (Cholestenone) test finally became consumer-accessible.
Roughly 30% of people diagnosed with IBS-D actually have bile acid diarrhea — a treatable transport disorder that produces identical symptoms but doesn't show up on any of the tests a colonoscopy workup runs. The diagnosis pathway exists. It just isn't part of standard primary-care workups in the US, so most patients spend years cycling through fiber, probiotics, and antispasmodics for a problem that responds to a $30 generic prescription within days of starting it.
This post walks through (1) why the standard IBD workup misses bile acid diarrhea, (2) the four-tier bile acid testing pathway your GI almost certainly didn't run, and (3) where each test is actually purchaseable as a self-pay consumer in the US — including the one Mayo specialty marker (7αC4 / Cholestenone) that until very recently had zero DTC availability.
Why your colonoscopy missed it
The classic IBS-D workup goes: stool culture, calprotectin, H. pylori, sometimes a CRP, then colonoscopy with biopsy. If everything is normal — and in bile acid diarrhea (BAD) everything will be normal — the patient is sent home with an IBS label and a dietary handout.
- BAD looks normal on a colonoscopy. Bile acid diarrhea doesn't inflame the mucosa, doesn't ulcerate, doesn't show histologic changes. The scope is clean. The biopsy is clean. The clinician concludes 'no IBD' — and then defaults to 'IBS, eat more fiber.'
- CRP, calprotectin, lactoferrin all come back normal. The standard inflammatory markers used to rule in/out IBD are designed to flag mucosal inflammation. BAD is a transport problem, not an inflammatory one. Every inflammatory test will read negative. The patient looks 'healthy' on paper.
- The label 'IBS-D' is functionally a dead end. Once a patient is labeled IBS-D, the workup typically stops. Bile acid testing isn't part of any standard IBS guideline in US primary care. The European societies recommend a SeHCAT scan; the SeHCAT isotope isn't available in the US, so US patients fall through the gap entirely.
- Bile acid sequestrants work — but no one tries them. Cholestyramine and colesevelam resolve symptoms in 70%+ of confirmed BAD cases. But empiric trials require a clinician willing to prescribe; without a positive test, most won't. The chain breaks at 'we have no easy way to test for this.'
The four-tier bile acid workup
Here's the test pathway your gastroenterologist could have ordered. Each tier is more specific (and more expensive) than the last; you climb the ladder until something flags. A normal Tier 1 rules out the cholestatic patterns; a positive Tier 2 or 3 confirms BAD and qualifies you for a sequestrant trial.
| Tier | Test | Specimen | Cheapest | Retailers |
|---|---|---|---|---|
| 1 | Total Bile Acids First screen. Elevated total in fasting serum is consistent with cholestasis or impaired bile flow. Cheap and broadly available. | Serum | $35.95 | 5 |
| 2 | Bile Acids, Fractionated and Total Splits primary (cholic, chenodeoxycholic) from secondary (deoxycholic). A primary-shifted pattern points away from gut dysbiosis; a secondary-shifted pattern points toward it. | Serum | $310 | 3 |
| 3 | 7αC4 / Cholestenone The synthesis-rate marker. Elevated 7αC4 means the liver is overproducing bile acids — the most direct serum signal of bile acid diarrhea (BAD). Sensitivity ~90% vs the 48-hour collection. | Serum | $269 | 1 |
| 4 | 48-Hour Fecal Bile Acids Gold standard for bile acid wasting. Quantifies excretion in mg/day across a 48-hour collection. Mayo only, physician order required, fat-controlled diet × 3 days. Not currently sold DTC. | Stool (timed) | — | 0 |
Tier 1 — Total Bile Acids
The cheapest screen on the ladder. Quest's enzymatic assay measures the total bile acid pool in fasting serum. Elevated values suggest cholestasis, impaired hepatic clearance, or a downstream transport problem worth investigating. A normal value doesn't rule out BAD — BAD often has normal totals — but it cleanly rules out the cholestatic patterns. Five US retailers carry it; cheapest is currently $35.95 at Ulta Lab Tests, with the same Quest assay available through Instalab at $49 and True Health Labs at $79. Compare all five →
Tier 2 — Fractionated Panel
A LabCorp-fulfilled panel that splits the bile acid pool into its constituent acids: cholic, chenodeoxycholic (the two primaries), and deoxycholic (the secondary). The primary-to-secondary ratio is the diagnostic signal — a high secondary fraction points toward gut dysbiosis (gut bacteria are over-deconjugating primary acids); a high primary fraction points toward fast transit or hepatic overproduction. Available at True Health Labs ($319), Walk-In Lab ($310), and Ulta ($302.95). Compare retailers →
Tier 3 — 7αC4 (Cholestenone)
The most direct serum marker for bile acid diarrhea — and the hardest test to find DTC. 7α-Hydroxy-4-cholesten-3-one (clinically: 7αC4, or just C4 in this context) is the immediate precursor in hepatic bile acid synthesis. When the liver is overproducing bile acids — exactly what happens in BAD — 7αC4 in the serum rises proportionally. Sensitivity vs the 48-hour collection is approximately 90%, and a single morning blood draw gets you the answer.
The catch: until 2025, this was effectively a Mayo-only specialty send-out. None of Walk-In Lab, Ulta, True Health Labs, DirectLabs, HealthLabs, Personalabs, RequestATest, LabsMD, Accesa, LabCorp OnDemand, or Quest's consumer arm carried it. Instalab is currently the only US DTC marketplace selling it ($269), routed through their specialty-lab partner. If you want this test without a physician referral, that's the one path. View 7αC4 retailer →
Tier 4 — 48-Hour Fecal Bile Acids (the unobtainable gold standard)
Mayo's BA48 test — a 48-hour timed stool collection that quantifies bile acid excretion in mg/day after a fat-controlled diet. It's the gold standard for confirming bile acid wasting. It's also not sold DTC anywhere on Earth, and that isn't a catalog gap — it's structural. The protocol requires a 100–150 g fat diet for three days before collection, exact timing of stool weights across 48 hours, and physician orders for the clinical interpretation. Self-pay-by-mail logistics genuinely cannot deliver any of that. If you've climbed to this tier, you need a GI willing to order through Mayo Clinic Labs directly.
What labhackr does for this workup
We've catalogued every DTC US lab marketplace that publicly lists prices for these markers. When you land on a component page — /components/cholestenone, /components/bile-acids, /components/cdca — you get every retailer carrying that marker, sorted cheapest first, with the per-store requisition fee folded into the total. Search by acronym (CDCA, TUDCA, 7αC4, UDCA) and the right marker surfaces; we maintain ~30 aliases per analyte covering chemical, abbreviated, and brand-name forms.
We don't sell the tests, and we don't take referrals from the labs. Affiliate commissions on the few retailers that have public partner programs are how the site funds itself — we surface every retailer regardless. If a price moves or a new retailer starts carrying a marker, the comparison updates the next time we re-scrape (currently weekly for the major catalogs).
What to actually do with this
If you've been labeled IBS-D and the workup stopped at a clean colonoscopy, the practical sequence is:
- Buy Tier 1. Order the $35.95 Total Bile Acids test. If elevated, you have a starting point for a hepatologist conversation about cholestatic patterns.
- If Tier 1 is normal but symptoms are textbook BAD (post-meal urgency, watery stools, worse after fatty foods, better with fasting) — go straight to Tier 3. The fractionated panel doesn't directly diagnose BAD; the synthesis-rate marker does.
- Take results to a GI willing to consider an empiric sequestrant trial. A positive 7αC4 plus a textbook history is enough for most gastroenterologists to prescribe colesevelam (Welchol) or cholestyramine. If symptoms resolve in 1-2 weeks, the diagnosis is functionally confirmed.
- If the GI insists on confirmatory testing, Mayo's BA48 (Tier 4) is the next step, and it requires going through their system via a referral. There is no DTC path for that one.
Disclaimer
This is not medical advice. labhackr is a price-comparison site; we surface retailers and prices for legally-available DTC lab tests. Bile acid diarrhea, cholestatic disease, and IBS-D have meaningful clinical overlap with conditions that need real clinician oversight (gallbladder disease, IBD, microscopic colitis, celiac, pancreatic insufficiency). Use these tests to inform a conversation with a GI or hepatologist, not to replace one.